Ernexa Therapeutics, Inc. (ERNA)
12.46
+1.06
(+9.30%)
USD |
NASDAQ |
May 21, 16:00
12.42
-0.04
(-0.32%)
After-Hours: 07:33
Ernexa Therapeutics Total Assets (Quarterly) : 10.54M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Quince Therapeutics, Inc. | 26.62M |
| Recursion Pharmaceuticals, Inc. | 1.340B |
| Tango Therapeutics, Inc. | 435.79M |
| Aprea Therapeutics, Inc. | 48.11M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.684M |
| Shareholders Equity (Quarterly) | 6.859M |
| Debt to Equity Ratio | 0.0567 |
| Current Ratio | 2.892 |
| Net Debt Paydown Yield | 1.02% |